358 related articles for article (PubMed ID: 8634430)
21. Clinical studies with megakaryocyte growth and development factor (Mpl-ligand).
Begley CG
Thromb Haemost; 1997 Jul; 78(1):42-6. PubMed ID: 9198125
[TBL] [Abstract][Full Text] [Related]
22. Constant subcutaneous infusion of rhIL-11 in mice: efficient delivery enhances biological activity.
Leonard JP; Neben TY; Kozitza MK; Quinto CM; Goldman SJ
Exp Hematol; 1996 Feb; 24(2):270-6. PubMed ID: 8641352
[TBL] [Abstract][Full Text] [Related]
23. In vivo effects of pegylated recombinant human megakaryocyte growth and development factor on hematopoiesis in normal mice.
Kabaya K; Akahori H; Shibuya K; Nitta Y; Ida M; Kusaka M; Kato T; Miyazaki H
Stem Cells; 1996 Nov; 14(6):651-60. PubMed ID: 8948023
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of thrombopoiesis in mice by fibroblast growth factor 9.
Matsumoto-Yoshitomi S; Seko C; Kuroshima K; Naruo K; Shino A; Kondo T; Kurokawa T
Growth Factors; 1995; 12(3):179-90. PubMed ID: 8619924
[TBL] [Abstract][Full Text] [Related]
25. Measurements of in vivo megakaryocytopoiesis: studies in nonhuman primates and patients.
Tomer A; Harker LA
Stem Cells; 1996; 14 Suppl 1():18-30. PubMed ID: 11012199
[TBL] [Abstract][Full Text] [Related]
26. Humanized VB22B minibody for human Mpl stimulates human megakaryopoiesis but does not enhance platelet aggregation.
Matsuki E; Miyakawa Y; Yamane A; Okamoto S
Exp Hematol; 2011 Aug; 39(8):829-36. PubMed ID: 21605620
[TBL] [Abstract][Full Text] [Related]
27. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of megakaryocytopoiesis in mice by human recombinant interleukin-6.
Hill RJ; Warren MK; Stenberg P; Levin J; Corash L; Drummond R; Baker G; Levin F; Mok Y
Blood; 1991 Jan; 77(1):42-8. PubMed ID: 1984802
[TBL] [Abstract][Full Text] [Related]
29. Thrombocytopenia in HIV infection: impairment of platelet formation and loss correlates with increased c-Mpl and ligand thrombopoietin expression.
Sundell IB; Koka PS
Curr HIV Res; 2006 Jan; 4(1):107-16. PubMed ID: 16454716
[TBL] [Abstract][Full Text] [Related]
30. Megakaryocyte growth and development factor (MGDF) moderately enhances in-vitro platelet aggregation.
Toombs CF; Young CH; Glaspy JA; Varnum BC
Thromb Res; 1995 Oct; 80(1):23-33. PubMed ID: 8578535
[TBL] [Abstract][Full Text] [Related]
31. The effects of Mpl-ligand, interleukin-6 and interleukin-11 on megakaryocyte and platelet alpha-granule proteins.
Philipp CS; Remmler J; Zucker-Franklin D
Thromb Haemost; 1998 Dec; 80(6):968-75. PubMed ID: 9869169
[TBL] [Abstract][Full Text] [Related]
32. Megakaryocyte growth and development factor stimulates enhanced platelet recovery in mice after bone marrow transplantation.
Molineux G; Hartley CA; McElroy P; McCrea C; McNiece IK
Blood; 1996 Aug; 88(4):1509-14. PubMed ID: 8695873
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer.
Vadhan-Raj S; Murray LJ; Bueso-Ramos C; Patel S; Reddy SP; Hoots WK; Johnston T; Papadopolous NE; Hittelman WN; Johnston DA; Yang TA; Paton VE; Cohen RL; Hellmann SD; Benjamin RS; Broxmeyer HE
Ann Intern Med; 1997 May; 126(9):673-81. PubMed ID: 9139552
[TBL] [Abstract][Full Text] [Related]
34. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
35. Thrombopoietin mobilizes CD34+ cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis.
Murray LJ; Luens KM; Estrada MF; Bruno E; Hoffman R; Cohen RL; Ashby MA; Vadhan-Raj S
Exp Hematol; 1998 Mar; 26(3):207-16. PubMed ID: 9502616
[TBL] [Abstract][Full Text] [Related]
36. The relationship between megakaryocyte ploidy and platelet volume in normal and thrombocytopenic C3H mice.
Corash L; Levin J
Exp Hematol; 1990 Oct; 18(9):985-9. PubMed ID: 2397753
[TBL] [Abstract][Full Text] [Related]
37. Effects of recombinant human megakaryocyte growth and development factor on platelet activation.
Montrucchio G; Brizzi MF; Calosso G; Marengo S; Pegoraro L; Camussi G
Blood; 1996 Apr; 87(7):2762-8. PubMed ID: 8639892
[TBL] [Abstract][Full Text] [Related]
38. Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice.
Yan XQ; Lacey D; Fletcher F; Hartley C; McElroy P; Sun Y; Xia M; Mu S; Saris C; Hill D; Hawley RG; McNiece IK
Blood; 1995 Dec; 86(11):4025-33. PubMed ID: 7492757
[TBL] [Abstract][Full Text] [Related]
39. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates.
Harker LA; Marzec UM; Kelly AB; Chronos NR; Sundell IB; Hanson SR; Herbert JM
Circulation; 1998 Dec; 98(22):2461-9. PubMed ID: 9832493
[TBL] [Abstract][Full Text] [Related]
40. Megakaryocytopoiesis induced by PEG-rHu megakaryocyte growth and development factor (MGDF).
Fattorossi A; Battaglia A; Bonanno G; Pierelli L; Scambia G; Benedetti Panici P; d'Onofrio G; Mancuso S; Leone G
Eur J Histochem; 1997; 41 Suppl 2():13-4. PubMed ID: 9859761
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
